A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML

Clinical trial NCT04730258 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04730258
Sponsor: Treadwell Therapeutics, Inc
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia AML MDS CMML

Start date: 2021-04-16
Primary completion: 2026-01-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.